Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
12.45
-0.13 (-1.03%)
Jan 26, 2026, 4:00 PM EST - Market closed
Passage Bio Employees
Passage Bio had 60 employees as of December 31, 2024. The number of employees increased by 2 or 3.45% compared to the previous year.
Employees
60
Change (1Y)
2
Growth (1Y)
3.45%
Revenue / Employee
n/a
Profits / Employee
-$754,400
Market Cap
39.57M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 60 | 2 | 3.45% |
| Dec 31, 2023 | 58 | -27 | -31.76% |
| Dec 31, 2022 | 85 | -48 | -36.09% |
| Dec 31, 2021 | 133 | 59 | 79.73% |
| Dec 31, 2020 | 74 | 54 | 270.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Generation Bio Co. | 115 |
| NextCure | 43 |
| Actinium Pharmaceuticals | 37 |
| Lantern Pharma | 24 |
| TuHURA Biosciences | 19 |
| Reviva Pharmaceuticals Holdings | 14 |
| Apollomics | 13 |
| Exicure | 7 |
PASG News
- 2 months ago - Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 2 months ago - Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 3 months ago - Passage Bio to Participate in Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 5 months ago - Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 6 months ago - Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 7 months ago - Passage Bio Announces 1-for-20 Reverse Stock Split - GlobeNewsWire
- 7 months ago - Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update - GlobeNewsWire
- 9 months ago - Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire